Augmentation of Immune Response to COVID-19 mRNA Vaccination Through Osteopathic Manipulative Treatment Including Lymphatic Pumps
The trial conducted by Western University of Health Sciences aimed to evaluate the potential of OMT to augment the immune response to mRNA COVID-19 vaccines. Given the ongoing concerns regarding vaccine efficacy against emerging variants and waning immunity, a successful outcome could position OMT as a complementary therapy in vaccination protocols, potentially expanding market opportunities in immunotherapy and preventive healthcare. The study's findings may attract interest from vaccine manufacturers and healthcare providers seeking to enhance vaccine effectiveness, thereby influencing competitive dynamics in the immunization landscape. Additionally, the collaboration with various osteopathic organizations may facilitate broader acceptance and integration of OMT in clinical practice, enhancing the commercial viability of this approach.
Indication: Covid19
Modality: RNA therapy
Target: Immune response enhancement via Osteopathic Manipulative Treatment (OMT) in conjunction with mRNA COVID-19 vaccination.
Sponsor: Western University of Health Sciences
Source URL: ClinicalTrials.gov
Source updated: Apr 26, 2024
Ingested: Jun 19, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Immune response enhancement via Osteopathic Manipulative Treatment (OMT) in conjunction with mRNA COVID-19 vaccination.
View original source fields
Condition raw: Covid19
Condition normalized: Covid19
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: Immune response enhancement via Osteopathic Manipulative Treatment (OMT) in conjunction with mRNA COVID-19 vaccination.
Target normalized: Immune response enhancement via Osteopathic Manipulative Treatment (OMT) in conjunction with mRNA COVID-19 vaccination.